| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2142609 | Lung Cancer | 2011 | 4 Pages |
Abstract
This study of erlotinib therapy in 2005-2007 confirms, in the general NSCLC patient population, the results of pivotal trials.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
A. Vergnenègre, I. Monnet, C. Chouaïd, J. Hureaux, J. Mazières, G. Quéré, J.N. Lombard, I. Cumin, S. Abdiche, C. Nocent Ejnaini, H. Bonnabau, Ch. Decroisette, the GFPC team the GFPC team,